Navann Ty
Stock Analyst at Exane BNP Paribas
(3.27)
# 2,457
Out of 5,055 analysts
38
Total ratings
55.6%
Success rate
7.1%
Average return
Main Sectors:
Stocks Rated by Navann Ty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OGN Organon & Co. | Downgraded: Hold | $15 → $14 | $13.74 | +1.89% | 6 | Apr 28, 2026 | |
| MDLN Medline | Initiated Coverage: Hold | $38 | $35.93 | +5.76% | 1 | Jan 12, 2026 | |
| NTRA Natera | Upgraded: Hold | $28 → $172 | $394.75 | -56.43% | 2 | Oct 27, 2025 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $92 | $68.47 | n/a | 1 | Sep 10, 2025 | |
| PAHC Phibro Animal Health | Reiterated: Hold | $24 → $37 | $38.02 | n/a | 2 | Sep 4, 2025 | |
| COO The Cooper Companies | Upgraded: Buy | $92 | $54.88 | n/a | 1 | Jul 22, 2025 | |
| KVUE Kenvue | Initiated Coverage: Hold | $28 | $18.01 | n/a | 1 | May 30, 2023 | |
| SKIN SkinHealth Systems | Upgraded: Hold | n/a | $11.56 | n/a | 2 | Mar 20, 2023 | |
| ABBV AbbVie | Initiated Coverage: Hold | $169 | $283.48 | n/a | 1 | Dec 8, 2022 | |
| EOLS Evolus | Initiated Coverage: Buy | $13 | $7.21 | n/a | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $26 | $39.08 | n/a | 2 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $11 | $17.44 | n/a | 2 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $232 → $208 | $75.29 | n/a | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $200 | $209.65 | n/a | 1 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $42 | $22.55 | n/a | 6 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37.06 → $52.74 | $8.40 | n/a | 3 | Mar 2, 2021 |
Organon & Co.
Apr 28, 2026
Downgraded: Hold
Price Target: $15 → $14
Current: $13.74
Upside: +1.89%
Medline
Jan 12, 2026
Initiated Coverage: Hold
Price Target: $38
Current: $35.93
Upside: +5.76%
Natera
Oct 27, 2025
Upgraded: Hold
Price Target: $28 → $172
Current: $394.75
Upside: -56.43%
GE HealthCare Technologies
Sep 10, 2025
Reiterated: Buy
Price Target: $92
Current: $68.47
Upside: n/a
Phibro Animal Health
Sep 4, 2025
Reiterated: Hold
Price Target: $24 → $37
Current: $38.02
Upside: n/a
The Cooper Companies
Jul 22, 2025
Upgraded: Buy
Price Target: $92
Current: $54.88
Upside: n/a
Kenvue
May 30, 2023
Initiated Coverage: Hold
Price Target: $28
Current: $18.01
Upside: n/a
SkinHealth Systems
Mar 20, 2023
Upgraded: Hold
Price Target: n/a
Current: $11.56
Upside: n/a
AbbVie
Dec 8, 2022
Initiated Coverage: Hold
Price Target: $169
Current: $283.48
Upside: n/a
Evolus
Dec 8, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $7.21
Upside: n/a
Mar 22, 2022
Reiterated: Hold
Price Target: $22 → $26
Current: $39.08
Upside: n/a
Mar 10, 2022
Reiterated: Hold
Price Target: $16 → $11
Current: $17.44
Upside: n/a
Mar 9, 2022
Reiterated: Hold
Price Target: $232 → $208
Current: $75.29
Upside: n/a
Oct 5, 2021
Initiated Coverage: Buy
Price Target: $200
Current: $209.65
Upside: n/a
May 17, 2021
Reiterated: Buy
Price Target: $39 → $42
Current: $22.55
Upside: n/a
Mar 2, 2021
Reiterated: Buy
Price Target: $37.06 → $52.74
Current: $8.40
Upside: n/a